SCHEMBL19009307

SCHEMBL19009307

c1ccc(-c2ccc3c(c2)c2c(-c4cccc(-c5ccc6c(c5)c5ncccc5n6-c5ccccc5)c4)cccc2n3-c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 4/20 0.41
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ATM Q13315 1/20 0.35
TOP1 P11387 2/20 0.34
ALDH1A1 P00352 2/20 0.32
TSHR P16473 2/20 0.32
CYP2C19 P33261 1/20 0.32
ACVR1 Q04771 2/20 0.32
GRM5 P41594 1/20 0.32
MEN1 O00255 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
KMT2A Q03164 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PIK3CA P42336 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19009318 0.99 ALK (0.40) ALKJAK2JAK3KDM4EL3MBTL1
SCHEMBL19009306 0.94 ALK (0.40) ALKJAK2JAK3KDM4EL3MBTL1
SCHEMBL17348661 0.93 ALK (0.38) ALKJAK2JAK3KDM4EL3MBTL1
SCHEMBL17348650 0.93 ALK (0.39) ALKJAK2JAK3KDM4EL3MBTL1
SCHEMBL19009300 0.93 ALK (0.39) ALKJAK2JAK3KDM4EL3MBTL1
SCHEMBL17348754 0.92 ALK (0.39) ALKKDM4EL3MBTL1ATMTOP1
SCHEMBL17348684 0.92 ALK (0.39) ALKKDM4EL3MBTL1ATMTOP1
SCHEMBL17348750 0.92 ALK (0.38) ALKKDM4EL3MBTL1ATMTOP1
SCHEMBL17348652 0.92 ALK (0.39) ALKKDM4EL3MBTL1ATMTOP1
SCHEMBL17348682 0.92 KDM4E (0.41) ALKJAK2JAK3KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597403-B2 Condensed cyclic compound, composition including the condensed cyclic compound, organic light-emitting device including the condensed cyclic compound, and method of manufacturing the organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-24 US disclosed
EP-3184522-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE Samsung Electronics Co., Ltd. (KR) 2017-06-28 EP disclosed
US-20170174705-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-06-22 US disclosed
US-20170174705-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174705-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE CRY1, C9, CRY2 ALK 4348/4885JAK2 3805/4885JAK3 3799/4885
US-10597403-B2 Condensed cyclic compound, composition including the condensed cyclic compound, organic light-emitting device including the condensed cyclic compound, and method of manufacturing the organic light-emitting device CRY1, C9, CRY2 ALK 4348/4885JAK2 3805/4885JAK3 3799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.